CAMELLINO, DARIO
 Distribuzione geografica
Continente #
EU - Europa 3.527
AS - Asia 596
NA - Nord America 344
SA - Sud America 57
AF - Africa 18
OC - Oceania 2
Totale 4.544
Nazione #
IT - Italia 3.464
US - Stati Uniti d'America 324
SG - Singapore 220
CN - Cina 169
VN - Vietnam 112
BD - Bangladesh 41
BR - Brasile 32
FR - Francia 26
HK - Hong Kong 20
AR - Argentina 10
DE - Germania 9
MX - Messico 8
CA - Canada 6
CL - Cile 6
GB - Regno Unito 6
ID - Indonesia 6
ZA - Sudafrica 6
FI - Finlandia 5
IQ - Iraq 5
IN - India 4
JM - Giamaica 4
CH - Svizzera 3
CO - Colombia 3
EC - Ecuador 3
MA - Marocco 3
PH - Filippine 3
AU - Australia 2
EG - Egitto 2
GH - Ghana 2
IE - Irlanda 2
NL - Olanda 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
AZ - Azerbaigian 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
PL - Polonia 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
SE - Svezia 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 4.544
Città #
Genova 1.384
Genoa 1.336
Vado Ligure 391
Rapallo 282
Singapore 108
San Jose 77
Ashburn 50
Ho Chi Minh City 30
Beijing 28
Lauterbourg 24
Hanoi 21
New York 19
Hong Kong 18
Council Bluffs 10
Milan 10
Santa Clara 10
St Louis 10
Bordighera 9
Rome 9
Los Angeles 7
Mexico City 7
Da Nang 6
Biên Hòa 4
Boardman 4
Tianjin 4
Dallas 3
Frankfurt am Main 3
Haiphong 3
Helsinki 3
Houston 3
Hải Dương 3
Johannesburg 3
Ninh Bình 3
Schiffdorf 3
Zurich 3
Accra 2
Ancona 2
Brooklyn 2
Buenos Aires 2
Buffalo 2
Bắc Giang 2
Bến Tre 2
Cagliari 2
Can Tho 2
Cardiff 2
Charleston 2
Chennai 2
Contagem 2
Florence 2
Guayaquil 2
Karbala 2
Kingston 2
Lappeenranta 2
London 2
Montego Bay 2
Montreal 2
Nha Trang 2
Orem 2
Pittsburgh 2
Portland 2
Rio de Janeiro 2
Sacramento 2
Santiago 2
Tacoma 2
Thái Bình 2
Tân Tiến 2
Viamão 2
Điện Bàn 2
Abbeville 1
Agadir 1
Altamonte Springs 1
Amsterdam 1
Aparecida 1
Ashland 1
Asyut 1
Atlanta 1
Auburn 1
Baghdad 1
Baku 1
Balikpapan 1
Baltimore 1
Batna City 1
Baton Rouge 1
Beaver Falls 1
Belleville 1
Belo Horizonte 1
Biñan 1
Bosa 1
Boston 1
Brasília 1
Budapest 1
Buin 1
Buon Ma Thuot 1
Bình Dương 1
Bắc Ninh 1
Cairo 1
Cajamar 1
Campagnano di Roma 1
Campinas 1
Cape Town 1
Totale 3.986
Nome #
A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View. 229
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography 186
Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by Koivuniemi et al. 185
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 182
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis 172
Seronegative spondyloarthropathies: what radiologists should know 169
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography 159
Ankylosis of the wrist bones in patients with rheumatoid arthritis: a study with extremity-dedicated MRI 151
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 146
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study 139
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 136
FRI0480 CHANGES IN CIRCULATING SCTLA-4 FOLLOWING ZOLEDRONIC ACID INFUSION 135
11. Steroid schedules in PMR 131
IMAGING AND SEROLOGICAL PROFILING OF PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS 122
Methotrexate treatment of polymyalgia rheumatica/giant cell arteritis-associated large vessel vasculitis. 119
Seronegative spondyloarthritis and Darier's disease: more than a casual association? 117
Cardiac and aortic involvement in patients with polymyalgia rheumatica: a study with echocardiography and FDG-PET/CT 113
Imaging in arthritis: quantifying effects of therapeutic intervention using MRI and molecular imaging. 109
The multifaceted pathogenesis of polymyalgia rheumatica/giant cell arteritis. 108
[Polymyalgia rheumatica and aortic involvement]. 108
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 104
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 99
AB0354 FDG-PET-DETECTED LARGE VESSEL VASCULITIS DOES NOT PREDICT DISEASE OUTCOME IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA 92
Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption 89
Extrusion of the medial meniscus in knee osteoarthritis assessed with a rotating clino-orthostatic permanent-magnet MRI scanner 88
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin 87
Seasonal onset of polymyalgia rheumatica: correlations with the pattern of clinical presentation, disease severity and outcome in 383 patients from a single centre. 67
Management of giant cell arteritis among general practitioners from Genoa, Italy: a web-based survey. 67
AB1289 HIGHER BASELINE FDG JOINT UPTAKE AT PET/CT IS ASSOCIATED WITH A HIGHER REMISSION RATE IN POLYMYALGIA RHEUMATICA: A RETROSPECTIVE 3-YEAR OBSERVATIONAL STUDY 67
The provisional OMERACT ultrasonography score for giant cell arteritis 66
Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review 65
Involvement of different knee structures reveleated by PET-CT in polymyalgia rheumatica 65
Soluble Co‐Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case‐Control Study 64
A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis 57
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides 55
Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: A systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica 54
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis 45
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: Executive summary 44
Are the new ACR/EULAR criteria the ultimate answer for polymyalgia rheumatica classification? 42
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC 41
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica 37
[Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease.] 36
From polymyalgia arteritica to arteritis polymyalgica: redefining the GCA-PMR spectrum through advanced MRI insights 29
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data 25
Treat to Target: A Valid Concept for Management of Polymyalgia Rheumatica and Giant Cell Arteritis? 25
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis 23
Update on treatment of polymyalgia rheumatica 23
AB0683 Treatment with statins in patients studied by fdg-pet/ct for possible large vessel vasculitis is associated with a low vascular score 21
Should 18F-FDG-PET imaging be used in the diagnosis of GCA? 18
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica 16
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica 16
Large vessel vasculitis: Is it more common than usually assumed? 15
Large vessel vasculitis: Which imaging method? 14
New insights into the role of imaging in polymyalgia rheumatica 14
Reply to: What could a new disease activity score for polymyalgia rheumatica do better? 14
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force 13
SAT0215 Twelve Year Follow-Up on Progression of Nailfold Microangiopathy Detected through Transition between Different Capillaroscopic Patterns of Microvascular Damage in Systemic Sclerosis 9
THU0454 Increased fdg uptake of the muscles in polymyalgia rheumatica (PMR) 7
FRI0369 Pattern of Clinical Presentation and Disease Severity in Patients with Polymyalgia Rheumatica 7
FRI0033 TNFalpha Production In Cultured Human Macrophages after CTLA4-IG (abatacept) In Vitro Treatment 6
Totale 4.642
Categoria #
all - tutte 15.751
article - articoli 14.858
book - libri 0
conference - conferenze 497
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022286 5 18 12 33 13 26 17 69 21 27 5 40
2022/2023332 28 61 3 24 40 47 3 18 42 5 61 0
2023/2024234 3 40 4 32 18 27 13 16 6 5 13 57
2024/2025925 21 115 32 65 105 95 66 160 14 30 88 134
2025/20261.724 215 52 189 164 196 95 207 71 163 188 158 26
Totale 4.642